Skip to main navigation
RXi Pharmaceuticals
  • Home
  • Contact Us
  • Company
    • Leadership
    • Career Opportunities
    • Contact Us
  • Technology
    • RNAi
      • About RNAi Mechanism
      • sd-rxRNA®
        • RXI-109
        • IncRNA
    • Publications
  • Immuno-Oncology
    • RXi’s Immunotherapy Approach
    • Immunotherapy of Cancer
  • Business Development
    • Intellectual Property Estate
    • Alliances and Collaborations
    • Partnering and Licensing Opportunities
      • Dermatology
        • Dermal Fibrosis
        • Consumer Health
        • Warts
          • Samcyprone
      • Ophthalmology
        • Retinal Fibrosis
        • Corneal Scarring
    • Research
      • Discovery Programs
      • OPKO Assets & Targets
  • Clinical Trials
    • RXi Clinical Trials
  • Investors
    • News Releases
    • Events & Presentations
      • Upcoming/Past Events
      • Presentations
      • Posters
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors & Scientific Board
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Institutional Ownership
      • Annual Reports
      • Form 8937
    • Email Alerts
    • Contact Us

Investors

  • Home
  • Investors
  • Events and Presentations
  • Posters

Posters

Title Date Documents

Nominating & Corporate Governance Committee

  • Add Files
    Nominating & Corporate Governance Committee 220.4 KB

12/19/2014 Release

  • Add Files
    12/19/2014 Release 178.3 KB

Corporation Amended & Restated Bylaws

  • Add Files
    Corporation Amended & Restated Bylaws 61.5 KB

Pagination

  • First page First
  • Previous page Previous
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
Displaying 111 - 113 of 113 results

Investors


  • News Releases
  • Events & Presentations
    • Upcoming/Past Events
    • Presentations
    • Posters
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors & Scientific Board
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Institutional Ownership
    • Annual Reports
    • Form 8937
  • Email Alerts
  • Contact Us
  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • IR Contact
  • Share

Contact

Main: 508-767-3861
FAX: 508-767-3862
E-mail: admin@rxipharma.com

Headquarters

257 Simarano Drive
Suite 101
Marlborough, MA 01752

FOLLOW US

RSS
Twitter
Linkedin

Legal

RXi Pharmaceuticals. All rights reserved.